vx has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardinger, CE; Berger, KE; Dunn, EN; Haines, KM; Jackson Piercy, CE; Lee-Stubbs, RB; Matson, LM; McCarren, HS; McDonough, JH; Miller-Smith, SM; Whitten, KA | 1 |
| Barry, J; Bohnert, S; Cochrane, L; Cornelissen, AS; Joosen, MJA; Kentrop, J; Klaassen, SD; Savransky, V; van Groningen, T | 1 |
| Aas, P; Enger, S; Mariussen, E; Myhrer, T | 1 |
| Cassel, G; Elfsmark, D; Göransson Nyberg, A; Heldestad, V; Rocksén, D; Wallgren, K | 1 |
| Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT | 1 |
| Breton, P; Daulon, S; Dorandeu, F; Foquin, A; Lallement, G; Perrier, N; Taysse, L | 1 |
| Boudry, I; Cruz, C; Daulon, S; Dorandeu, F; Foquin, A; Hérodin, F; Lallement, G; Mathieu, J; Taysse, L | 1 |
| Bartel, TB; Chen, C; Lowe, VJ; Nagarkar, V; Shafirstein, G; Siegel, E; Singh, B; Stack, BC; Thacker, S; Ye, J | 1 |
| Joosen, MJ; Kuijpers, WC; Noort, D; van der Schans, MJ; van Helden, HP | 1 |
| Grauer, E; Levy, A | 1 |
1 review(s) available for vx and Disease Models, Animal
| Article | Year |
|---|---|
Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Decontamination; Disease Models, Animal; Guinea Pigs; Organophosphate Poisoning; Organothiophosphorus Compounds; Procyclidine; Pyridostigmine Bromide; Scopolamine; Skin; Time Factors | 2013 |
9 other study(ies) available for vx and Disease Models, Animal
| Article | Year |
|---|---|
Evaluation of fosphenytoin, levetiracetam, and propofol as treatments for nerve agent-induced seizures in pediatric and adult rats.
Topics: Age Factors; Animals; Anticonvulsants; Brain; Disease Models, Animal; Female; Levetiracetam; Male; Organothiophosphorus Compounds; Phenytoin; Propofol; Rats, Sprague-Dawley; Sarin; Sex Factors; Status Epilepticus | 2020 |
Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Disease Models, Animal; Drug Combinations; Guinea Pigs; Male; Muscarinic Antagonists; Obidoxime Chloride; Organothiophosphorus Compounds; Treatment Outcome | 2021 |
Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats.
Topics: Animals; Anticonvulsants; Antidotes; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Lethal Dose 50; Levetiracetam; Male; Nerve Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Piracetam; Procyclidine; Pyridinium Compounds; Rats; Rats, Wistar; Seizures; Soman | 2015 |
An animal model to study health effects during continuous low-dose exposure to the nerve agent VX.
Topics: Acetylcholinesterase; Animals; Blood Pressure; Chemical Warfare Agents; Cholinesterase Inhibitors; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Male; Organothiophosphorus Compounds; Osmosis; Rats; Rats, Wistar; Respiration; Telemetry; Thyroid Gland; Thyroxine; Weight Gain | 2008 |
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors | 2009 |
Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
Topics: Aluminum Compounds; Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Decontamination; Diacetyl; Disease Models, Animal; Magnesium Compounds; Male; Mice; Mice, Hairless; Mustard Gas; Organothiophosphorus Compounds; Polyethylene Glycols; Silicates; Skin | 2011 |
Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse. (I) Development of a model for screening studies in skin decontamination and protection.
Topics: Animals; Chemical Warfare Agents; Decontamination; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Mice; Mice, Hairless; Mustard Gas; Organothiophosphorus Compounds; Skin; Skin Tests | 2011 |
Orthotopic VX rabbit tongue cancer model with FDG-PET and histologic characterization.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Neoplasm Transplantation; Organothiophosphorus Compounds; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Tongue Neoplasms | 2013 |
Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
Topics: Aldicarb; Animals; Body Temperature; Carbamates; Central Nervous System; Cholinesterase Inhibitors; Disease Models, Animal; Hypothermia; Lethal Dose 50; Male; Muscarinic Agonists; Muscarinic Antagonists; N-Methylscopolamine; Organophosphorus Compounds; Organothiophosphorus Compounds; Oxotremorine; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Recovery of Function; Reproducibility of Results; Sarin; Seizures; Time Factors; Toxicity Tests | 2007 |